{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:26:39Z","timestamp":1777418799802,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Bial Portela & Companhia S.A"},{"name":"Centro Industrial Santiga","award":["6, 08130"],"award-info":[{"award-number":["6, 08130"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.yrtph.2019.104547","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T12:25:39Z","timestamp":1575635139000},"page":"104547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Oral repeated-dose toxicity studies of BIA 10\u20132474 in cynomolgus monkeys"],"prefix":"10.1016","volume":"111","author":[{"given":"Klaus","family":"Weber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00fcdiger","family":"H\u00e4cker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry F.","family":"Hardisty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6316-3179","authenticated-orcid":false,"given":"A. Wallace","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2019.104547_bib1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1517\/17460440903018857","article-title":"Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders","volume":"4","author":"Ahn","year":"2009","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.yrtph.2019.104547_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrd3620","article-title":"The pharmacological landscape and therapeutic potential of serine hydrolases","volume":"11","author":"Bachovchin","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.yrtph.2019.104547_bib3","series-title":"Report by the temporary specialist scientific committee (TSSC): FAAH (fatty acid amide hydrolase),\u201d on the causes of the accident during a phase 1 clinical trial in rennes in January 2016","author":"CSST","year":"2016"},{"key":"10.1016\/j.yrtph.2019.104547_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008877-200402000-00001","article-title":"Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development","volume":"15","author":"De Vry","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104547_bib5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1369-1600.2010.00261.x","article-title":"Neurological soft signs in non-psychotic patients with cannabis dependence","volume":"18","author":"Dervaux","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.yrtph.2019.104547_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/HPC.0b013e318057d4b4","article-title":"The endocannabinoid system: a new target for the regulation of energy balance and metabolism","volume":"6","author":"Despr\u00e9s","year":"2007","journal-title":"Crit. Pathw Cardiol."},{"key":"10.1016\/j.yrtph.2019.104547_bib6","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1080\/01621459.1955.10501294","article-title":"A multiple comparison procedure for comparing several treatments with a control","volume":"50","author":"Dunnett","year":"1955","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.yrtph.2019.104547_bib7","article-title":"Preliminary safety evaluation in study BIA-10-2474-101","author":"Gama","year":"2016","journal-title":"Proc. Br. Pharmacol. Soc."},{"key":"10.1016\/j.yrtph.2019.104547_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.02.696","article-title":"Blood levels do not predict behavioral or physiological effects of \u0394\u2079-tetrahydrocannabinol in rhesus monkeys with different patterns of exposure","volume":"139","author":"Ginsburg","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.yrtph.2019.104547_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/187152709789824660","article-title":"The endocannabinoid system and pain","volume":"8","author":"Guindon","year":"2009","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.yrtph.2019.104547_bib10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pnpbp.2010.11.002","article-title":"The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects","volume":"35","author":"Hallak","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.yrtph.2019.104547_bib11","article-title":"Oral repeated-dose toxicity studies of BIA 10-2474 in beagle dogs","author":"Hardisty","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104547_bib12","article-title":"Developmental and reproductive toxicity studies of BIA 10-2474","author":"Harris","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104547_bib13","article-title":"Oral repeated-dose toxicity studies of BIA 10-2474 in Wistar rat","author":"Hayes","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104547_bib14","article-title":"The absence of genotoxicity of a novel fatty acid amide hydrolase inhibitor, BIA 10-2474","author":"Hayes","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104547_bib15","article-title":"Oral repeated-dose toxicity studies of BIA 10-2474 in CD-1 mice","author":"Hayes","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104547_bib16","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJMoa1604221","article-title":"Acute neurologic disorder from an inhibitor of fatty acid amide hydrolase","volume":"375","author":"Kerbrat","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yrtph.2019.104547_bib17","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1002\/cmdc.201800393","article-title":"Discovery of a potent, long-acting, and CNS-active inhibitor (BIA 10-2474) of fatty acid amide hydrolase","volume":"13","author":"Kiss","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.yrtph.2019.104547_bib18","series-title":"Simultaneous Statistical Inferences","author":"Miller","year":"1981"},{"key":"10.1016\/j.yrtph.2019.104547_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1124\/jpet.106.106377","article-title":"Preclinical assessment of candidate analgesic drugs: recent advances and future challenges","volume":"319","author":"Negus","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yrtph.2019.104547_bib20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.yrtph.2019.104547_bib21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/cpt.118","article-title":"Cannabinoid abuse and addiction: clinical and preclinical findings","volume":"97","author":"Panlilio","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.yrtph.2019.104547_bib22","first-page":"51","article-title":"FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels","volume":"11","author":"Petrosino","year":"2010","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.yrtph.2019.104547_bib23","article-title":"Tolerability, pharmacokinetic and pharmacodynamic profile of BIA 10-2474 in healthy volunteers following multiple ascending doses","author":"Rocha","year":"2016","journal-title":"Proc. Br. Pharmacol. Soc."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230019303113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230019303113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:29:20Z","timestamp":1759494560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230019303113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":24,"alternative-id":["S0273230019303113"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2019.104547","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral repeated-dose toxicity studies of BIA 10\u20132474 in cynomolgus monkeys","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2019.104547","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104547"}}